Clinical trial
Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
NCT00421213 is registered in ClinicalTrials.gov with Alaunos Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
- Lead sponsor
- Alaunos Therapeutics
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- December 29, 2006
- Completion date
- June 30, 2009
- Enrollment
- 50 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
bone marrow neoplasms, hematologic neoplasms, non-hodgkin's lymphoma